de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374–403.

Article  PubMed  Google Scholar 

Ma T, Chen Z, Chai Y, Gongye X, Xia P, Qu C, et al. Research progress on immunotherapy targeting the tumor immune microenvironment for cholangiocarcinoma. Oncol Transl Med. 2023;9(2):49–55.

Article  CAS  Google Scholar 

Jia Q, Wang A, Yuan Y, Zhu B, Long H. Heterogeneity of the tumor immune microenvironment and its clinical relevance. Exp Hematol Oncol. 2022;11(1):24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46.

Article  CAS  PubMed  Google Scholar 

Jin H, Wang L, Bernards R. Rational combinations of targeted cancer therapies: background, advances and challenges. Nat Rev Drug Discov. 2023;22(3):213–34.

Article  CAS  PubMed  Google Scholar 

Aldea M, Andre F, Marabelle A, Dogan S, Barlesi F, Soria JC. Overcoming resistance to tumor-targeted and immune-targeted therapies. Cancer Discov. 2021;11(4):874–99.

Article  CAS  PubMed  Google Scholar 

Ma W, Xue R, Zhu Z, Farrukh H, Song W, Li T, et al. Increasing cure rates of solid tumors by immune checkpoint inhibitors. Exp Hematol Oncol. 2023;12(1):10.

Article  PubMed  PubMed Central  Google Scholar 

Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu SYM, Zheng MM, Pan Y, Liu SY, Li Y, Wu YL. Emerging evidence and treatment paradigm of non-small cell lung cancer. J Hematol Oncol. 2023;16(1):40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Varaprasad GL, Gupta VK, Prasad K, Kim E, Tej MB, Mohanty P, et al. Recent advances and future perspectives in the therapeutics of prostate cancer. Exp Hematol Oncol. 2023;12(1):80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scott EC, Baines AC, Gong Y, Moore R, Pamuk GE, Saber H, et al. Trends in the approval of cancer therapies by the FDA in the twenty-first century. Nat Rev Drug Discov. 2023;22(8):625–40.

Article  CAS  PubMed  Google Scholar 

Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21(1):28.

Article  PubMed  PubMed Central  Google Scholar 

Wu M, Huang Q, Xie Y, Wu X, Ma H, Zhang Y, et al. Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation. J Hematol Oncol. 2022;15(1):24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Huang L, Gu Y, Cang W, Sun P, Xiang Y. Lactate-lactylation hands between metabolic reprogramming and immunosuppression. Int J Mol Sci. 2022;23(19):11943.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27(8):1482–92.

Article  CAS  PubMed  Google Scholar 

Guo L, Kong D, Liu J, Zhan L, Luo L, Zheng W, et al. Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol. 2023;12(1):3.

Article  PubMed  PubMed Central  Google Scholar 

Li M, Yang Y, Xiong L, Jiang P, Wang J, Li C. Metabolism, metabolites, and macrophages in cancer. J Hematol Oncol. 2023;16(1):80.

Article  PubMed  PubMed Central  Google Scholar 

Chen ZQ, Zuo XL, Cai J, Zhang Y, Han GY, Zhang L, et al. Hypoxia-associated circPRDM4 promotes immune escape via HIF-1α regulation of PD-L1 in hepatocellular carcinoma. Exp Hematol Oncol. 2023;12(1):17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bylicki O, Barazzutti H, Paleiron N, Margery J, Assié JB, Chouaïd C. First-line treatment of non-small-cell lung cancer (NSCLC) with immune checkpoint inhibitors. BioDrugs. 2019;33(2):159–71.

Article  CAS  PubMed  Google Scholar 

Giroux Leprieur E, Dumenil C, Julie C, Giraud V, Dumoulin J, Labrune S, et al. Immunotherapy revolutionises non-small-cell lung cancer therapy: results, perspectives and new challenges. Eur J Cancer. 2017;78:16–23.

Article  CAS  PubMed  Google Scholar 

Labrie M, Brugge JS, Mills GB, Zervantonakis IK. Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer. Nat Rev Cancer. 2022;22(6):323–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu L, Zou C, Zhang S, Chu TSM, Zhang Y, Chen W, et al. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. J Hematol Oncol. 2022;15(1):87.

Article  PubMed  PubMed Central  Google Scholar 

Liao X, Li X, Liu R. Extracellular-matrix mechanics regulate cellular metabolism: A ninja warrior behind mechano-chemo signaling crosstalk. Rev Endocr Metab Disord. 2023;24(2):207–20.

Article  CAS  PubMed  Google Scholar 

Nia HT, Munn LL, Jain RK. Physical traits of cancer. Science. 2020;370(6516):eaaz868.

Article  Google Scholar 

Zhang J, Li J, Hou Y, Lin Y, Zhao H, Shi Y, et al. Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor. Cell. 2024;187(13):3409-3426.e24.

Article  CAS  PubMed  Google Scholar 

Xu Z, Li K, Xin Y, Tang K, Yang M, Wang G, et al. Fluid shear stress regulates the survival of circulating tumor cells via nuclear expansion. J Cell Sci. 2022;135(10):jcs259586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Mao S, Khan M, Zhang Q, Huang Q, Feng S, et al. Responses of cellular adhesion strength and stiffness to fluid shear stress during tumor cell rolling motion. ACS Sens. 2019;4(6):1710–5.

Article  CAS  PubMed  Google Scholar 

Slack RJ, Macdonald SJF, Roper JA, Jenkins RG, Hatley RJD. Emerging therapeutic opportunities for integrin inhibitors. Nat Rev Drug Discov. 2022;21(1):60–78.

Article  CAS  PubMed  Google Scholar 

Janmey PA, Fletcher DA, Reinhart-King CA. Stiffness sensing by cells. Physiol Rev. 2020;100(2):695–724.

Article  CAS  PubMed  Google Scholar 

Su Z, Chen Z, Ma K, Chen H, Ho JWK. Molecular determinants of intrinsic cellular stiffness in health and disease. Biophys Rev. 2022;14(5):1197–209.

Article  PubMed  PubMed Central  Google Scholar